News | MRI Breast | September 15, 2015

BEST Act ensures quality screening and treatment options throughout state

Komen, Rep. Smiddy, BEST Act, breast cancer law, screening, MRI, Illinois

September 15, 2015 — The Susan G. Komen Illinois Affiliates applaud Rep. Mike Smiddy (D-Hillsdale) on the passage of the Breast Cancer Excellence in Survival and Treatment Act (BEST Act, HB3673) into law.

The new legislation acts as an amendment to the Illinois Insurance Code and the Illinois Public Aid Code as it relates to coverage and payment for screening by low-dose mammography for all women 35 years of age or older for the presence of occult breast cancer.

Key components of the new legislation include:

  • Requirement for all Medicaid health plans to include American College of Radiology Breast Centers of Imaging Excellence and Academic or Comprehensive Commission on Cancer Accredited centers in their networks, so that women can access the highest quality care;
  • Establishment of a breast cancer treatment quality program and expanded help to women diagnosed with breast cancer who are navigating the healthcare system; and
  • Ensuring medically necessary magnetic resonance imaging (MRI) screening as recommended by a licensed physician will be covered by insurance in Illinois.

The final version of the legislation passed both houses on May 31, and Illinois Gov. Bruce Rauner signed the bill into law on August 21.  

Sean Tenner, Komen Chicago's board president, began working with Rep. Smiddy over 18 months ago when Smiddy's wife, Deb, was fighting breast cancer.

"We applaud Representative Smiddy on his efforts to ensure Illinois women have access to necessary breast health services, and making breast cancer a top priority this past legislative session," Tenner noted.

For more information: www.ilga.gov/legislation


Related Content

News | Breast Imaging

May 28, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time May 28, 2024
arrow
News | FDA

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
News | Radiology Business

May 6, 2024 — ScreenPoint Medical’s Board of Directors has announced the appointment of Peter Kroese as the new Chief ...

Time May 06, 2024
arrow
News | Mammography

May 6, 2024 — Enable Me, a VELA Medical company, cited major new research by Siemens Healthineers entitled, “The future ...

Time May 06, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
arrow
Feature | Breast Density | By Robert L. Bard, MD

Decades since the advent of breast scanning technology, innovations in noninvasive diagnostic imaging provide new ...

Time May 03, 2024
arrow
News | Breast Imaging

May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...

Time May 01, 2024
arrow
News | Breast Imaging

May 1, 2024 — The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast ...

Time May 01, 2024
arrow
News | Breast Imaging

May 1, 2024 — After the issuance of updated breast screening recommendations by the U.S. Preventive Services Task Force ...

Time May 01, 2024
arrow
Subscribe Now